Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164K Buy
1,122
+21
+2% +$3.81K 0.01% 135
2026
Q1
$162K Sell
1,101
-224
-17% -$36.4K 0.01% 116
2025
Q4
$258K Sell
1,325
-7,878
-86% -$1.88M 0.03% 76
2025
Q3
$2.59M Buy
9,203
+313
+4% +$79.7K 0.47% 32
2025
Q2
$1.94M Sell
8,890
-1,055
-11% -$170K 0.38% 34
2025
Q1
$1.39M Sell
9,945
-298
-3% -$48.5K 0.29% 46
2024
Q4
$1.71M Buy
10,243
+1,366
+15% +$243K 0.36% 32
2024
Q3
$1.51M Buy
8,877
+35
+0.4% +$5.07K 0.33% 39
2024
Q2
$1.25M Sell
8,842
-1,535
-15% -$191K 0.29% 45
2024
Q1
$1.3M Sell
10,377
-55
-0.5% -$6.29K 0.33% 41
2023
Q4
$1.1M Sell
10,432
-15,517
-60% -$1.69M 0.31% 44
2023
Q3
$2.75M Buy
+25,949
New +$3M 1.13% 34

Other funds holding ORCL

Arlington Trust's ORCL Position: Q2 2026 in Review

Arlington Trust increased its Oracle (ORCL) stake by 1.9% in Q2 2026, buying an estimated $3.81K and bringing the position to 1,122 shares worth $164K. The position accounts for 0.01% of the portfolio, ranked #135.

Arlington Trust first reported a position in ORCL in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.75M in Q3 2023. 1,495 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Arlington Trust held 1,122 shares of Oracle worth $164K as of Q2 2026.
  • Arlington Trust bought 21 Oracle shares in Q2 2026, an estimated $3.81K.
  • Oracle made up 0.01% of Arlington Trust's portfolio in Q2 2026, its #135 holding.
  • Arlington Trust first reported a position in Oracle in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's Oracle position peaked at $2.75M in Q3 2023.
  • 1,495 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.